Ginkgo Bioworks Holdings, Inc. (DNA) Earnings Per Share (EPS)
Ginkgo Bioworks Holdings, Inc. (DNA) earnings per share history, EPS estimates, and growth trends. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2021-12-31 | -$54.00 |
| 2022-12-31 | -$50.00 |
| 2023-12-31 | -$18.40 |
| 2024-12-31 | -$10.54 |
| 2025-12-31 | -$5.64 |
How DNA compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| CELC | Celcuity Inc. | -$3.79 |
| ATOS | Atossa Therapeutics Inc. | -$4.04 |
| RARE | Ultragenyx Pharmaceutical Inc. | -$5.83 |
| BHVN | Biohaven Ltd. | -$6.86 |
| AGIO | Agios Pharmaceuticals Inc. | -$7.12 |
These are five companies in the same sector as DNA with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Ginkgo Bioworks Holdings, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("DNA")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | DNA | $7.65 | -4.02% | 1.32M |
| 3 | ||||
| 4 | ||||
| 5 |